Bank of America’s Syra Health Corp. Class A Common Stock SYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-77
Closed -$20 8780
2025
Q1
$20 Sell
77
-124
-62% -$52 ﹤0.01% 8142
2024
Q4
$83 Sell
201
-29
-13% -$12 ﹤0.01% 7781
2024
Q3
$98 Buy
230
+214
+1,338% +$227 ﹤0.01% 7728
2024
Q2
$22 Buy
+16
New +$22 ﹤0.01% 7986
2024
Q1
Sell
-2
Closed -$2 8271
2023
Q4
$2 Buy
+2
New +$3 ﹤0.01% 7916

Other funds holding SYRA

Bank of America's SYRA Position: Q2 2025 in Review

Bank of America sold out of Syra Health Corp. Class A Common Stock (SYRA) in Q2 2025, closing a stake of 77 shares — an estimated $20 sold.

Bank of America first reported a position in SYRA in Q4 2023 and held it in 5 quarters. The position peaked at $98 in Q3 2024. 2 funds tracked by Wall St. Rank hold SYRA as of Q2 2025.

  • Bank of America reported no remaining Syra Health Corp. Class A Common Stock position as of Q2 2025 after selling out during the quarter.
  • Bank of America sold 77 Syra Health Corp. Class A Common Stock shares in Q2 2025, an estimated $20.
  • Bank of America first reported a position in Syra Health Corp. Class A Common Stock in Q4 2023 and held it in 5 quarters.
  • Bank of America's Syra Health Corp. Class A Common Stock position peaked at $98 in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Syra Health Corp. Class A Common Stock as of Q2 2025.

Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.